Reduced 11 -Hydroxysteroid Dehydrogenase Type 2 Activity Is Associated with Decreased Birth Weight Centile in Pregnancies Complicated by Asthma
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Pregnancies complicated by asthma are associated with an increased risk of low birth weight. Currently, the mechanisms causing this outcome are unknown. To investigate whether impaired placental function may be a determinant, we measured placental 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) activity, protein and mRNA, placental CRH mRNA, fetal cortisol, and fetal estriol concentrations at delivery. Asthmatic subjects were classified according to inhaled glucocorticoid intake during pregnancy and compared with a control nonasthmatic group. There was a 25% reduction in neonatal birth weight centile in asthmatic women who did not use inhaled glucocorticoid treatment. This was accompanied by significantly reduced placental 11beta-HSD2 activity, significantly increased fetal cortisol, and a trend toward increased placental CRH mRNA and reduced fetal estriol concentrations. The use of inhaled glucocorticoids for treatment was associated with birth weight centile, 11beta-HSD2 activity, CRH mRNA, fetal cortisol, and estriol concentrations similar to control levels. There was a significant inverse correlation between fetal cortisol and fetal estriol concentrations across all groups. These studies demonstrate that inhaled glucocorticoid intake for the treatment of asthma is associated with improved placental function and fetal outcome, suggesting that inflammatory factors associated with asthma may be detrimental to fetal growth and development in these pregnancies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Perinatal complications associated with maternal tobacco use
Andres, R. L., & Day, M.-C. (2000) · Seminars in Neonatology · doi:10.1053/siny.2000.0025 · Cited by 524
Shams, M., Kilby, M. D., Somerset, D. A., Howie, A. J., Gupta, A., Wood, P. J., Afnan, M., & Stewart, P. M. (1998) · Human Reproduction · doi:10.1093/humrep/13.4.799 · Cited by 276
Fried, M., Muga, R. O., Misore, A. O., & Duffy, P. E. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.5.2523 · Cited by 262
Krozowski, Z., MaGuire, J. A., Stein-Oakley, A. N., Dowling, J., Smith, R. E., & Andrews, R. K. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.7.7608280 · Cited by 252
Self-citationDarnel, A. D., Archer, T. K., & Yang, K. (1999) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(99)00116-8 · Cited by 44
Cited by
11β-hydroxysteroid dehydrogenases: Intracellular gate-keepers of tissue glucocorticoid action
Chapman, K., Holmes, M., & Seckl, J. (2013) · Physiological Reviews · doi:10.1152/physrev.00020.2012 · Cited by 887
Prenatal glucocorticoids and long-term programming
Seckl (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.151u049 · Cited by 825
“Indeed, lack of glucocorticoid therapy is associated with a reduction in offspring birth weight (17).”
BackgroundResultSeckl, J. R., & Holmes, M. C. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0515 · Cited by 754
Endocrine Regulation of Human Fetal Growth: The Role of the Mother, Placenta, and Fetus
Murphy, V. E., Smith, R., Giles, W. B., & Clifton, V. L. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0011 · Cited by 671
Self-citationEpigenetic mechanisms of perinatal programming of hypothalamic-pituitary-adrenal function and health
Meaney, M. J., Szyf, M., & Seckl, J. R. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.05.003 · Cited by 668
Prenatal stress, glucocorticoids and the programming of adult disease
Cottrell, E. C. (2009) · Frontiers in Behavioral Neuroscience · doi:10.3389/neuro.08.019.2009 · Cited by 640
“In support of this notion, in human and rodent pregnancy fetal weight is correlated with 11β-HSD2 activity (Stewart et al., 1995; Lindsay et al., 1996; Murphy et al., 2002).”
BackgroundSECKL, J. R., & MEANEY, M. J. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1314.006 · Cited by 556
A meta-analysis of adverse perinatal outcomes in women with asthma
Murphy, V., Namazy, J., Powell, H., Schatz, M., Chambers, C., Attia, J., & Gibson, P. (2011) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2011.03055.x · Cited by 350
Self-citationMaternal Asthma Is Associated with Reduced Female Fetal Growth
Murphy, V. E., Gibson, P. G., Giles, W. B., Zakar, T., Smith, R., Bisits, A. M., Kessell, C. G., & Clifton, V. L. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200303-374oc · Cited by 295
Self-citationBusse, W. W. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.10.023 · Cited by 288
Severe Asthma Exacerbations During Pregnancy
Murphy, V. E., Gibson, P., Talbot, P. I., & Clifton, V. L. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000185281.21716.02 · Cited by 275
Self-citationGlucocorticoids, developmental ‘programming’ and the risk of affective dysfunction
Seckl, J. R. (2007) · Progress in Brain Research · doi:10.1016/s0079-6123(07)67002-2 · Cited by 245
11β-Hydroxysteroid dehydrogenases and the brain: From zero to hero, a decade of progress
Wyrwoll, C. S., Holmes, M. C., & Seckl, J. R. (2011) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2010.12.001 · Cited by 244
“In support, placental 11b-HSD2 correlates with birth parameters in rodents and, less consistently, in humans [21,190,262] suggesting that normal variation in fetal exposure to maternal glucocorticoids impact on fetal growth.”
Palma-Gudiel, H., Córdova-Palomera, A., Eixarch, E., Deuschle, M., & Fañanás, L. (2015) · Epigenetics · doi:10.1080/15592294.2015.1088630 · Cited by 240
Glucocorticoid “Programming” and PTSD Risk
SECKL, J. R., & MEANEY, M. J. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1364.027 · Cited by 234
Holmes, M. C., Abrahamsen, C. T., French, K. L., Paterson, J. M., Mullins, J. J., & Seckl, J. R. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4464-05.2006 · Cited by 200
Kivlighan, K. T., DiPietro, J. A., Costigan, K. A., & Laudenslager, M. L. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.06.008 · Cited by 176
Altered Placental Function of 11β-Hydroxysteroid Dehydrogenase 2 Knockout Mice
Wyrwoll, C. S., Seckl, J. R., & Holmes, M. C. (2009) · Endocrinology · doi:10.1210/en.2008-1100 · Cited by 169
Cuffe, J. S. M., Walton, S. L., Singh, R. R., Spiers, J. G., Bielefeldt‐Ohmann, H., Wilkinson, L., Little, M. H., & Moritz, K. M. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.272856 · Cited by 128
“This was also associated with increased placental Crh mRNA levels (Murphy et al. 2002).”
BackgroundReconciling the nutritional and glucocorticoid hypotheses of fetal programming
Cottrell, E. C., Holmes, M. C., Livingstone, D. E., Kenyon, C. J., & Seckl, J. R. (2012) · The FASEB Journal · doi:10.1096/fj.12-203489 · Cited by 102
Study, T. N. B. D. P., Hoyt, A. T., Browne, M., Richardson, S., Romitti, P., & Druschel, C. (2014) · Maternal and Child Health Journal · doi:10.1007/s10995-013-1397-4 · Cited by 58
Behavioral epigenetics and the developmental origins of child mental health disorders
Lester, B. M., Marsit, C. J., Conradt, E., Bromer, C., & Padbury, J. F. (2012) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174412000426 · Cited by 48
Freedman, R., Hunter, S. K., Noonan, K., Wyrwa, A., Christians, U., Law, A. J., & Hoffman, M. C. (2021) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2020.08.003 · Cited by 19
“Female placentas are larger and presumably better able to support the smaller female fetus, perhaps insuring that more females survive adversity in utero to bear their own progeny (79).”
Background
Metadata
- Authors
- Murphy, V. E.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2002-04-01
- Volume
- 87
- Issue
- 4
- Pages
- 1660-1668
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W1979325449
- Cited by
- 135
- References
- 5
- FWCI
- 5.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.